Prostate-specific antigen after neoadjuvant androgen suppression in prostate cancer patients receiving short-term androgen suppression and external beam radiotherapy: pooled analysis of four NRG Oncology RTOG randomized clinical trials

PURPOSE: To validate if prostate specific antigen (PSA) level after neoadjuvant androgen suppression (neoAS) is associated with long-term outcome after neoAS and external radiation therapy (RT) with concurrent short-term AS in prostate cancer patients. METHODS: 2404 patients treated with neoAS prior...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Radiat Oncol Biol Phys
Prif Awduron: Hallemeier, Christopher L, Zhang, Peixin, Pisansky, Thomas M, Hanks, Gerald E, McGowan, David G, Roach, Mack, Zeitzer, Kenneth L, Firat, Selim Y, Husain, Siraj M, D’Souza, David P, Souhami, Luis, Parliament, Matthew B., Rosenthal, Seth A, Lukka, Himanshu R, Rotman, Marvin, Horwitz, Eric M, Miles, Edward F, Paulus, Rebecca, Sandler, Howard M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6646073/
https://ncbi.nlm.nih.gov/pubmed/30959123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.03.049
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg